COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?

Abstract Coronavirus disease 2019 (COVID-19) induced by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has impacted the lives and wellbeing of many people. This globally widespread disease poses a significant public health concern that urges to discover an effective treatment....

Full description

Bibliographic Details
Main Authors: Chow Suet-May, Kuok Sin-Yee, Lee Jia-Qing, Goh Pey-Wen, Harleen Kaur A/P Ranjit Singh, Timothy Tan Zhi-Zheng, Jhi-Biau Foo, Sharina Hamzah, Renukha Sellappans, Yow Hui-Yin1comma2comma3*
Format: Article
Language:English
Published: Knowledge E 2022-12-01
Series:Sudan Journal of Medical Sciences
Subjects:
Online Access:https://doi.org/10.18502/sjms.v17i4.12550
_version_ 1828070547368443904
author Chow Suet-May
Kuok Sin-Yee
Lee Jia-Qing
Goh Pey-Wen
Harleen Kaur A/P Ranjit Singh
Timothy Tan Zhi-Zheng
Jhi-Biau Foo
Sharina Hamzah
Renukha Sellappans
Yow Hui-Yin1comma2comma3*
author_facet Chow Suet-May
Kuok Sin-Yee
Lee Jia-Qing
Goh Pey-Wen
Harleen Kaur A/P Ranjit Singh
Timothy Tan Zhi-Zheng
Jhi-Biau Foo
Sharina Hamzah
Renukha Sellappans
Yow Hui-Yin1comma2comma3*
author_sort Chow Suet-May
collection DOAJ
description Abstract Coronavirus disease 2019 (COVID-19) induced by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has impacted the lives and wellbeing of many people. This globally widespread disease poses a significant public health concern that urges to discover an effective treatment. This review paper discusses the effectiveness of repurposed drugs used to treat COVID-19 and potential novel therapies for COVID-19. Among the various repurposed drugs, remdesivir is the only agent approved by the Food and Drug Administration (FDA) to treat COVID-19. On the other hand, several drugs have been listed in the Emergency Use Authorization (EUA) by the FDA to treat COVID-19, including casirivimab and imdevimab, baricitinib (in combination with remdesivir), bamlanivimab, tocilizumab, and IL-6 inhibitors. In addition, in vitro and clinical studies have suggested cepharanthine, sotrovimab, and XAV-19 as potential treatments to manage COVID-19. Due to inadequate understanding of COVID-19 and the rapid mutation of SARS-CoV-2, COVID-19 remains a threat to global public health, with vaccination considered the most effective method to decrease COVID-19 transmission currently. Nevertheless, with the intense efforts of clinical researchers globally, more promising treatments for COVID-19 will be established in the future.
first_indexed 2024-04-11T00:39:27Z
format Article
id doaj.art-abf4e2709d994d76bbb80863b9f64b54
institution Directory Open Access Journal
issn 1858-5051
language English
last_indexed 2024-04-11T00:39:27Z
publishDate 2022-12-01
publisher Knowledge E
record_format Article
series Sudan Journal of Medical Sciences
spelling doaj.art-abf4e2709d994d76bbb80863b9f64b542023-01-06T10:23:13ZengKnowledge ESudan Journal of Medical Sciences1858-50512022-12-0117449853810.18502/sjms.v17i4.12550sjms.v17i4.12550COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?Chow Suet-May0Kuok Sin-Yee1Lee Jia-Qing2Goh Pey-Wen3Harleen Kaur A/P Ranjit Singh4Timothy Tan Zhi-Zheng5Jhi-Biau Foo6Sharina Hamzah7Renukha Sellappans8Yow Hui-Yin1comma2comma3* School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Malaysia School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Malaysia School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Malaysia School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Malaysia School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Malaysia School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Malaysia School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Malaysia School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Malaysia School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, MalaysiaAbstract Coronavirus disease 2019 (COVID-19) induced by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has impacted the lives and wellbeing of many people. This globally widespread disease poses a significant public health concern that urges to discover an effective treatment. This review paper discusses the effectiveness of repurposed drugs used to treat COVID-19 and potential novel therapies for COVID-19. Among the various repurposed drugs, remdesivir is the only agent approved by the Food and Drug Administration (FDA) to treat COVID-19. On the other hand, several drugs have been listed in the Emergency Use Authorization (EUA) by the FDA to treat COVID-19, including casirivimab and imdevimab, baricitinib (in combination with remdesivir), bamlanivimab, tocilizumab, and IL-6 inhibitors. In addition, in vitro and clinical studies have suggested cepharanthine, sotrovimab, and XAV-19 as potential treatments to manage COVID-19. Due to inadequate understanding of COVID-19 and the rapid mutation of SARS-CoV-2, COVID-19 remains a threat to global public health, with vaccination considered the most effective method to decrease COVID-19 transmission currently. Nevertheless, with the intense efforts of clinical researchers globally, more promising treatments for COVID-19 will be established in the future.https://doi.org/10.18502/sjms.v17i4.12550covid-19, sars-cov-2, treatment, drug repurposing, antiviral agents
spellingShingle Chow Suet-May
Kuok Sin-Yee
Lee Jia-Qing
Goh Pey-Wen
Harleen Kaur A/P Ranjit Singh
Timothy Tan Zhi-Zheng
Jhi-Biau Foo
Sharina Hamzah
Renukha Sellappans
Yow Hui-Yin1comma2comma3*
COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
Sudan Journal of Medical Sciences
covid-19, sars-cov-2, treatment, drug repurposing, antiviral agents
title COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
title_full COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
title_fullStr COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
title_full_unstemmed COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
title_short COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
title_sort covid 19 how effective are the repurposed drugs and novel agents in treating the infection
topic covid-19, sars-cov-2, treatment, drug repurposing, antiviral agents
url https://doi.org/10.18502/sjms.v17i4.12550
work_keys_str_mv AT chowsuetmay covid19howeffectivearetherepurposeddrugsandnovelagentsintreatingtheinfection
AT kuoksinyee covid19howeffectivearetherepurposeddrugsandnovelagentsintreatingtheinfection
AT leejiaqing covid19howeffectivearetherepurposeddrugsandnovelagentsintreatingtheinfection
AT gohpeywen covid19howeffectivearetherepurposeddrugsandnovelagentsintreatingtheinfection
AT harleenkaurapranjitsingh covid19howeffectivearetherepurposeddrugsandnovelagentsintreatingtheinfection
AT timothytanzhizheng covid19howeffectivearetherepurposeddrugsandnovelagentsintreatingtheinfection
AT jhibiaufoo covid19howeffectivearetherepurposeddrugsandnovelagentsintreatingtheinfection
AT sharinahamzah covid19howeffectivearetherepurposeddrugsandnovelagentsintreatingtheinfection
AT renukhasellappans covid19howeffectivearetherepurposeddrugsandnovelagentsintreatingtheinfection
AT yowhuiyin1comma2comma3 covid19howeffectivearetherepurposeddrugsandnovelagentsintreatingtheinfection